DNA Biomed Solns Cash Flow Reinvestment Rate

Latest as of December 2022: 0.00x

DNA Biomed Solns cash flow reinvestment rate. DNA Biomed Solns (DNA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting ILA0.00 (capex ILA0.00 ) from operating cash flow of ILA394.50K. See DNA Biomed Solns leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

ILA0.00

Capex + Investments

Operating Cash Flow

ILA394.50K

ILA

Capital Expenditures

ILA0.00

ILA

Cash Flow Reinvestment Rate of DNA Biomed Solns (2024–2024)

Cash flow reinvestment rate of DNA Biomed Solns from 2024 to 2024. Historical reinvestment intensity for DNA Biomed Solns across 1 annual periods. Explore DNA Biomed Solns debt service capacity to assess how comfortably operating cash covers total debt obligations.

DNA Biomed Solns Cash Flow Reinvestment Rate by Year (2024–2024)

DNA Biomed Solns cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for DNA Biomed Solns. For the full cash flow conversion analysis, see DNA Biomed Solns (DNA) cash conversion ratio.

Year	Reinvestment Rate	Total Reinvested (ILA)	Operating CF	Capex	YoY Change
2024	0.00x	ILA0.00	ILA1.61 Million	ILA0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow